Does OSA therapy improve cardiovascular autonomic function in patients with obstructive sleep apnea?
OSA therapy reduces sympathetic activity, which may mediate a reduction in cardiovascular disease risk in patients with OSA.
OSA therapy selectively improves autonomic function measures. The strongest evidence for the effect of OSA therapy on autonomic function was seen in reduced sympathetic activity as assessed by microneurography, but without increased improvement in parasympathetic function. OSA therapy may reduce the risk of cardiovascular disease in OSA through reduced sympathetic activity.
Dissanayake et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: